25 XP   0   0   10

Teyi Pharmaceutical Group Co Ltd
Buy, Hold or Sell?

Let's analyse Teyi Pharmaceutical Group Co Ltd together

PenkeI guess you are interested in Teyi Pharmaceutical Group Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Teyi Pharmaceutical Group Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Teyi Pharmaceutical Group Co Ltd

I send you an email if I find something interesting about Teyi Pharmaceutical Group Co Ltd.

Quick analysis of Teyi Pharmaceutical Group Co Ltd (30 sec.)










What can you expect buying and holding a share of Teyi Pharmaceutical Group Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.12
When do you have the money?
1 year
How often do you get paid?
87.5%

What is your share worth?

Current worth
¥5.51
Expected worth in 1 year
¥7.18
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
¥2.51
Return On Investment
26.5%

For what price can you sell your share?

Current Price per Share
¥9.47
Expected price per share
¥8.0428298393914 - ¥16.28
How sure are you?
50%

1. Valuation of Teyi Pharmaceutical Group Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥9.47

Intrinsic Value Per Share

¥8.39 - ¥9.89

Total Value Per Share

¥13.90 - ¥15.40

2. Growth of Teyi Pharmaceutical Group Co Ltd (5 min.)




Is Teyi Pharmaceutical Group Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$277.4m$176.1m$52.9m23.1%

How much money is Teyi Pharmaceutical Group Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$8.7m$6.1m$2.5m29.6%
Net Profit Margin23.1%19.2%--

How much money comes from the company's main activities?

3. Financial Health of Teyi Pharmaceutical Group Co Ltd (5 min.)




What can you expect buying and holding a share of Teyi Pharmaceutical Group Co Ltd? (5 min.)

Welcome investor! Teyi Pharmaceutical Group Co Ltd's management wants to use your money to grow the business. In return you get a share of Teyi Pharmaceutical Group Co Ltd.

What can you expect buying and holding a share of Teyi Pharmaceutical Group Co Ltd?

First you should know what it really means to hold a share of Teyi Pharmaceutical Group Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Teyi Pharmaceutical Group Co Ltd is ¥9.47. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Teyi Pharmaceutical Group Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Teyi Pharmaceutical Group Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥5.51. Based on the TTM, the Book Value Change Per Share is ¥0.42 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.10 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.21 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Teyi Pharmaceutical Group Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.020.3%0.020.2%0.010.1%0.010.1%0.010.1%
Usd Book Value Change Per Share0.111.2%0.060.6%0.010.1%0.020.2%0.020.2%
Usd Dividend Per Share0.000.0%0.030.3%0.030.3%0.020.2%0.010.1%
Usd Total Gains Per Share0.111.2%0.090.9%0.040.4%0.040.4%0.030.3%
Usd Price Per Share2.47-2.45-2.28-2.17-2.75-
Price to Earnings Ratio25.26-34.39-48.21-97.28-99.10-
Price-to-Total Gains Ratio21.75-45.99-125.75-190.32-261.05-
Price to Book Ratio3.25-3.98-4.67-4.66-7.59-
Price-to-Total Gains Ratio21.75-45.99-125.75-190.32-261.05-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.30686
Number of shares765
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.030.02
Usd Book Value Change Per Share0.060.02
Usd Total Gains Per Share0.090.04
Gains per Quarter (765 shares)66.1429.11
Gains per Year (765 shares)264.54116.44
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1891762556452106
2177352520129104222
3266528785193156338
43557031050257208454
54438791315322260570
653210551580386312686
762112311845451364802
871014072110515417918
9798158323755794691034
10887175826406445211150

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%40.00.00.0100.0%
Book Value Change Per Share3.01.00.075.0%9.03.00.075.0%15.05.00.075.0%33.06.01.082.5%33.06.01.082.5%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%35.00.05.087.5%35.00.05.087.5%
Total Gains per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%40.00.00.0100.0%

Fundamentals of Teyi Pharmaceutical Group Co Ltd

About Teyi Pharmaceutical Group Co Ltd

Teyi Pharmaceutical Group Co.,Ltd engages in the research and development, production, and sale of proprietary Chinese medicines, chemical preparations, raw materials, and products in the People's Republic of China. The company offers cough and phlegm, kidney, anti- infection, cardiovascular and cerebrovascular, and digestive system drugs. Its chemical raw materials and products include aluminum magnesium carbonate, phenytoin, ferrous sulfate, glacial acetic acid, calcium chloride, sodium chloride, bismuth series, citric acid series, zinc sulfate, etc. The company was formerly known as Guangdong Taicheng Pharmaceutical Co., Ltd. and changed its name to Teyi Pharmaceutical Group Co.,Ltd in November 2016. Teyi Pharmaceutical Group Co.,Ltd was founded in 2002 and is based in Taishan, the People's Republic of China.

Fundamental data was last updated by Penke on 2024-04-14 19:11:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Teyi Pharmaceutical Group Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Teyi Pharmaceutical Group Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Teyi Pharmaceutical Group Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 20.1% means that ¥0.20 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Teyi Pharmaceutical Group Co Ltd:

  • The MRQ is 20.1%. The company is making a huge profit. +2
  • The TTM is 23.1%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ20.1%TTM23.1%-3.0%
TTM23.1%YOY19.2%+3.9%
TTM23.1%5Y16.9%+6.2%
5Y16.9%10Y17.3%-0.4%
1.1.2. Return on Assets

Shows how efficient Teyi Pharmaceutical Group Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Teyi Pharmaceutical Group Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 2.6% Return on Assets means that Teyi Pharmaceutical Group Co Ltd generated ¥0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Teyi Pharmaceutical Group Co Ltd:

  • The MRQ is 2.6%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.6%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ2.6%TTM2.6%0.0%
TTM2.6%YOY1.9%+0.7%
TTM2.6%5Y1.7%+0.9%
5Y1.7%10Y1.8%-0.1%
1.1.3. Return on Equity

Shows how efficient Teyi Pharmaceutical Group Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Teyi Pharmaceutical Group Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 3.2% Return on Equity means Teyi Pharmaceutical Group Co Ltd generated ¥0.03 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Teyi Pharmaceutical Group Co Ltd:

  • The MRQ is 3.2%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 3.9%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ3.2%TTM3.9%-0.7%
TTM3.9%YOY3.4%+0.5%
TTM3.9%5Y3.0%+0.9%
5Y3.0%10Y3.1%-0.1%

1.2. Operating Efficiency of Teyi Pharmaceutical Group Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Teyi Pharmaceutical Group Co Ltd is operating .

  • Measures how much profit Teyi Pharmaceutical Group Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Teyi Pharmaceutical Group Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Teyi Pharmaceutical Group Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM5.6%-5.6%
TTM5.6%YOY16.9%-11.2%
TTM5.6%5Y16.6%-10.9%
5Y16.6%10Y10.1%+6.5%
1.2.2. Operating Ratio

Measures how efficient Teyi Pharmaceutical Group Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.20 means that the operating costs are ¥1.20 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Teyi Pharmaceutical Group Co Ltd:

  • The MRQ is 1.203. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.159. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.203TTM1.159+0.044
TTM1.159YOY1.274-0.115
TTM1.1595Y1.234-0.075
5Y1.23410Y0.916+0.318

1.3. Liquidity of Teyi Pharmaceutical Group Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Teyi Pharmaceutical Group Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 2.37 means the company has ¥2.37 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Teyi Pharmaceutical Group Co Ltd:

  • The MRQ is 2.373. The company is able to pay all its short-term debts. +1
  • The TTM is 1.503. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.373TTM1.503+0.870
TTM1.503YOY1.269+0.234
TTM1.5035Y1.247+0.256
5Y1.24710Y0.745+0.502
1.3.2. Quick Ratio

Measures if Teyi Pharmaceutical Group Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Teyi Pharmaceutical Group Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.21 means the company can pay off ¥0.21 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Teyi Pharmaceutical Group Co Ltd:

  • The MRQ is 0.210. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.140. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.210TTM0.140+0.070
TTM0.140YOY0.216-0.075
TTM0.1405Y0.316-0.175
5Y0.31610Y0.376-0.061

1.4. Solvency of Teyi Pharmaceutical Group Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Teyi Pharmaceutical Group Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Teyi Pharmaceutical Group Co Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.20 means that Teyi Pharmaceutical Group Co Ltd assets are financed with 20.0% credit (debt) and the remaining percentage (100% - 20.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Teyi Pharmaceutical Group Co Ltd:

  • The MRQ is 0.200. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.311. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.200TTM0.311-0.111
TTM0.311YOY0.431-0.120
TTM0.3115Y0.439-0.128
5Y0.43910Y0.397+0.042
1.4.2. Debt to Equity Ratio

Measures if Teyi Pharmaceutical Group Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Teyi Pharmaceutical Group Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 25.0% means that company has ¥0.25 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Teyi Pharmaceutical Group Co Ltd:

  • The MRQ is 0.250. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.467. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.250TTM0.467-0.218
TTM0.467YOY0.768-0.301
TTM0.4675Y0.818-0.351
5Y0.81810Y0.720+0.098

2. Market Valuation of Teyi Pharmaceutical Group Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Teyi Pharmaceutical Group Co Ltd generates.

  • Above 15 is considered overpriced but always compare Teyi Pharmaceutical Group Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 25.26 means the investor is paying ¥25.26 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Teyi Pharmaceutical Group Co Ltd:

  • The EOD is 13.348. Based on the earnings, the company is underpriced. +1
  • The MRQ is 25.258. Based on the earnings, the company is overpriced. -1
  • The TTM is 34.393. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD13.348MRQ25.258-11.910
MRQ25.258TTM34.393-9.135
TTM34.393YOY48.211-13.818
TTM34.3935Y97.278-62.884
5Y97.27810Y99.104-1.827
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Teyi Pharmaceutical Group Co Ltd:

  • The EOD is 8.482. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 16.050. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is -62.746. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD8.482MRQ16.050-7.568
MRQ16.050TTM-62.746+78.796
TTM-62.746YOY81.270-144.016
TTM-62.7465Y-1.421-61.326
5Y-1.42110Y-182.910+181.489
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Teyi Pharmaceutical Group Co Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Teyi Pharmaceutical Group Co Ltd:

  • The EOD is 1.718. Based on the equity, the company is underpriced. +1
  • The MRQ is 3.251. Based on the equity, the company is fair priced.
  • The TTM is 3.975. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD1.718MRQ3.251-1.533
MRQ3.251TTM3.975-0.725
TTM3.975YOY4.674-0.699
TTM3.9755Y4.657-0.682
5Y4.65710Y7.586-2.929
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Teyi Pharmaceutical Group Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.8140.416+96%0.097+740%0.123+560%0.138+491%
Book Value Per Share--5.5134.552+21%3.500+58%3.426+61%2.841+94%
Current Ratio--2.3731.503+58%1.269+87%1.247+90%0.745+218%
Debt To Asset Ratio--0.2000.311-36%0.431-54%0.439-55%0.397-50%
Debt To Equity Ratio--0.2500.467-47%0.768-67%0.818-69%0.720-65%
Dividend Per Share--0.0100.210-95%0.210-95%0.152-94%0.098-90%
Eps--0.1770.133+33%0.099+79%0.093+90%0.082+116%
Free Cash Flow Per Share--0.2790.077+262%0.193+45%0.098+186%0.048+482%
Free Cash Flow To Equity Per Share--0.279-0.135+149%0.020+1276%-0.086+131%0.062+347%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--9.892--------
Intrinsic Value_10Y_min--8.390--------
Intrinsic Value_1Y_max--0.567--------
Intrinsic Value_1Y_min--0.557--------
Intrinsic Value_3Y_max--2.027--------
Intrinsic Value_3Y_min--1.929--------
Intrinsic Value_5Y_max--3.877--------
Intrinsic Value_5Y_min--3.571--------
Market Cap3454078405.760-89%6536123023.3606475038357.995+1%6025479293.685+8%5726582971.409+14%7274443224.761-10%
Net Profit Margin--0.2010.231-13%0.192+5%0.169+19%0.173+16%
Operating Margin---0.056-100%0.169-100%0.166-100%0.101-100%
Operating Ratio--1.2031.159+4%1.274-6%1.234-2%0.916+31%
Pb Ratio1.718-89%3.2513.975-18%4.674-30%4.657-30%7.586-57%
Pe Ratio13.348-89%25.25834.393-27%48.211-48%97.278-74%99.104-75%
Price Per Share9.470-89%17.92017.753+1%16.520+8%15.700+14%19.944-10%
Price To Free Cash Flow Ratio8.482-89%16.050-62.746+491%81.270-80%-1.421+109%-182.910+1240%
Price To Total Gains Ratio11.496-89%21.75345.989-53%125.745-83%190.318-89%261.046-92%
Quick Ratio--0.2100.140+49%0.216-3%0.316-34%0.376-44%
Return On Assets--0.0260.026-1%0.019+33%0.017+51%0.018+45%
Return On Equity--0.0320.039-18%0.034-5%0.030+7%0.031+3%
Total Gains Per Share--0.8240.626+31%0.306+169%0.276+199%0.236+249%
Usd Book Value--277474103.652229131820.518+21%176160306.472+58%172442234.703+61%142978946.725+94%
Usd Book Value Change Per Share--0.1120.057+96%0.013+740%0.017+560%0.019+491%
Usd Book Value Per Share--0.7610.628+21%0.483+58%0.473+61%0.392+94%
Usd Dividend Per Share--0.0010.029-95%0.029-95%0.021-94%0.014-90%
Usd Eps--0.0240.018+33%0.014+79%0.013+90%0.011+116%
Usd Free Cash Flow--14049523.8383881635.428+262%9708085.563+45%4909804.851+186%2354957.564+497%
Usd Free Cash Flow Per Share--0.0390.011+262%0.027+45%0.013+186%0.007+482%
Usd Free Cash Flow To Equity Per Share--0.039-0.019+149%0.003+1276%-0.012+131%0.009+347%
Usd Market Cap476662819.995-89%901984977.224893555293.403+1%831516142.529+8%790268450.054+14%1003873165.017-10%
Usd Price Per Share1.307-89%2.4732.450+1%2.280+8%2.167+14%2.752-10%
Usd Profit--8927708.4928734564.742+2%6148041.598+45%5339387.150+67%4456673.353+100%
Usd Revenue--44424907.53836818817.825+21%30586697.382+45%29433750.973+51%25380336.442+75%
Usd Total Gains Per Share--0.1140.086+31%0.042+169%0.038+199%0.033+249%
 EOD+4 -4MRQTTM+25 -10YOY+28 -75Y+28 -710Y+25 -10

3.2. Fundamental Score

Let's check the fundamental score of Teyi Pharmaceutical Group Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1513.348
Price to Book Ratio (EOD)Between0-11.718
Net Profit Margin (MRQ)Greater than00.201
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.210
Current Ratio (MRQ)Greater than12.373
Debt to Asset Ratio (MRQ)Less than10.200
Debt to Equity Ratio (MRQ)Less than10.250
Return on Equity (MRQ)Greater than0.150.032
Return on Assets (MRQ)Greater than0.050.026
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Teyi Pharmaceutical Group Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5021.127
Ma 20Greater thanMa 5015.159
Ma 50Greater thanMa 10015.140
Ma 100Greater thanMa 20016.684
OpenGreater thanClose9.720
Total3/5 (60.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Net Interest Income  -1,230-1,309-2,539994-1,54512-1,5332,326793



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets2,512,637
Total Liabilities501,955
Total Stockholder Equity2,010,682
 As reported
Total Liabilities 501,955
Total Stockholder Equity+ 2,010,682
Total Assets = 2,512,637

Assets

Total Assets2,512,637
Total Current Assets1,105,153
Long-term Assets1,407,484
Total Current Assets
Cash And Cash Equivalents 647,247
Net Receivables 97,808
Inventory 271,832
Other Current Assets 1,757
Total Current Assets  (as reported)1,105,153
Total Current Assets  (calculated)1,018,643
+/- 86,510
Long-term Assets
Property Plant Equipment 656,487
Goodwill 529,228
Intangible Assets 164,638
Long-term Assets Other 15,548
Long-term Assets  (as reported)1,407,484
Long-term Assets  (calculated)1,365,901
+/- 41,583

Liabilities & Shareholders' Equity

Total Current Liabilities465,765
Long-term Liabilities36,189
Total Stockholder Equity2,010,682
Total Current Liabilities
Short Long Term Debt 306,000
Accounts payable 83,003
Other Current Liabilities 3,149
Total Current Liabilities  (as reported)465,765
Total Current Liabilities  (calculated)392,152
+/- 73,614
Long-term Liabilities
Long-term Liabilities  (as reported)36,189
Long-term Liabilities  (calculated)0
+/- 36,189
Total Stockholder Equity
Retained Earnings 517,500
Total Stockholder Equity (as reported)2,010,682
Total Stockholder Equity (calculated)517,500
+/- 1,493,182
Other
Capital Stock364,687
Common Stock Shares Outstanding 364,687
Net Invested Capital 2,316,682
Net Working Capital 639,388
Property Plant and Equipment Gross 1,004,143



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312012-12-312011-12-31
> Total Assets 
283,212
388,220
453,544
0
460,787
821,142
825,603
851,990
1,179,679
1,243,098
1,598,084
1,575,338
1,549,393
1,605,066
1,603,188
1,583,972
1,538,255
1,573,098
1,928,985
1,903,879
1,902,314
2,003,379
2,067,598
2,195,896
2,207,486
2,319,806
2,256,809
2,352,331
2,148,844
2,132,024
2,256,116
2,021,690
1,908,375
1,923,291
2,066,196
2,005,314
2,188,220
2,273,043
2,545,605
2,498,982
2,160,044
2,450,671
2,512,637
2,512,6372,450,6712,160,0442,498,9822,545,6052,273,0432,188,2202,005,3142,066,1961,923,2911,908,3752,021,6902,256,1162,132,0242,148,8442,352,3312,256,8092,319,8062,207,4862,195,8962,067,5982,003,3791,902,3141,903,8791,928,9851,573,0981,538,2551,583,9721,603,1881,605,0661,549,3931,575,3381,598,0841,243,0981,179,679851,990825,603821,142460,7870453,544388,220283,212
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
749,144
802,669
824,854
942,933
942,737
1,029,377
935,128
1,036,032
821,242
787,720
929,214
689,601
553,307
547,147
711,950
633,702
809,234
892,741
1,128,867
1,080,605
740,973
1,035,026
1,105,153
1,105,1531,035,026740,9731,080,6051,128,867892,741809,234633,702711,950547,147553,307689,601929,214787,720821,2421,036,032935,1281,029,377942,737942,933824,854802,669749,14400000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
138,078
186,090
460,625
180,178
163,664
241,615
123,603
160,542
170,605
164,880
325,121
319,524
224,269
219,880
372,470
255,619
433,632
532,156
739,660
700,881
350,734
604,807
647,247
647,247604,807350,734700,881739,660532,156433,632255,619372,470219,880224,269319,524325,121164,880170,605160,542123,603241,615163,664180,178460,625186,090138,07800000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
240,000
0
0
0
405,000
0
450,000
510,000
285,000
285,000
250,000
30,000
0
0
0
30,000
10,000
0
0
0
0
13,000
0
013,000000010,00030,00000030,000250,000285,000285,000510,000450,0000405,000000240,00000000000000000000000
       Net Receivables 
51,500
69,319
92,421
0
0
95,056
102,089
121,605
138,188
166,087
170,275
167,232
143,960
135,415
129,720
116,877
106,739
113,717
118,585
140,293
154,867
202,016
162,849
100,208
99,573
99,625
152,641
147,769
131,231
131,181
143,465
128,816
99,351
112,099
128,023
130,538
129,581
113,648
93,470
60,528
111,050
80,865
97,808
97,80880,865111,05060,52893,470113,648129,581130,538128,023112,09999,351128,816143,465131,181131,231147,769152,64199,62599,573100,208162,849202,016154,867140,293118,585113,717106,739116,877129,720135,415143,960167,232170,275166,087138,188121,605102,08995,0560092,42169,31951,500
       Other Current Assets 
10,011
25,857
18,136
0
329,487
25,056
32,209
37,893
43,929
63,149
60,936
164,238
26,391
34,983
31,023
32,517
30,206
30,717
16,537
284,690
39,163
237,580
23,727
378,270
406,054
406,146
13,710
24,668
11,775
11,278
17,585
22,484
14,679
10,483
15,449
20,638
19,922
19,987
3,248
1,978
30,987
1,842
1,757
1,7571,84230,9871,9783,24819,98719,92220,63815,44910,48314,67922,48417,58511,27811,77524,66813,710406,146406,054378,27023,727237,58039,163284,69016,53730,71730,20632,51731,02334,98326,391164,23860,93663,14943,92937,89332,20925,056329,487018,13625,85710,011
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,252,963
1,264,749
1,290,429
1,321,681
1,316,299
1,327,602
1,344,304
1,326,902
1,332,089
1,355,068
1,376,144
1,354,247
1,371,612
1,378,987
1,380,302
1,416,737
1,418,377
1,419,070
1,415,646
1,407,484
1,407,4841,415,6461,419,0701,418,3771,416,7371,380,3021,378,9871,371,6121,354,2471,376,1441,355,0681,332,0891,326,9021,344,3041,327,6021,316,2991,321,6811,290,4291,264,7491,252,96300000000000000000000000
       Property Plant Equipment 
37,487
48,369
116,667
0
0
112,962
113,841
132,260
233,594
239,262
291,613
289,097
336,051
339,249
349,921
345,594
451,680
451,633
457,746
461,917
469,782
470,174
481,006
482,387
476,810
476,567
522,720
519,354
538,258
542,418
554,226
549,572
578,123
573,186
601,684
605,533
608,792
614,817
648,014
654,920
660,232
655,526
656,487
656,487655,526660,232654,920648,014614,817608,792605,533601,684573,186578,123549,572554,226542,418538,258519,354522,720476,567476,810482,387481,006470,174469,782461,917457,746451,633451,680345,594349,921339,249336,051289,097291,613239,262233,594132,260113,841112,96200116,66748,36937,487
       Goodwill 
0
0
0
0
0
0
0
0
381,948
381,948
587,876
587,876
587,876
587,876
587,876
587,876
587,876
587,876
587,876
587,876
587,876
587,876
587,876
587,876
587,876
587,876
587,876
587,876
587,876
587,876
565,452
565,452
565,452
565,452
542,395
542,395
542,395
542,395
542,395
542,395
542,395
542,395
529,228
529,228542,395542,395542,395542,395542,395542,395542,395542,395565,452565,452565,452565,452587,876587,876587,876587,876587,876587,876587,876587,876587,876587,876587,876587,876587,876587,876587,876587,876587,876587,876587,876587,876381,948381,94800000000
       Intangible Assets 
18,652
18,186
59
0
0
17,370
17,254
17,139
428,228
427,905
665,191
664,320
663,507
662,642
661,804
660,990
660,142
659,348
658,545
657,673
69,176
86,638
128,420
154,431
69,547
166,257
168,582
166,901
165,432
163,422
166,195
173,068
174,128
171,737
172,150
169,918
170,827
167,795
165,225
163,791
162,114
164,396
164,638
164,638164,396162,114163,791165,225167,795170,827169,918172,150171,737174,128173,068166,195163,422165,432166,901168,582166,25769,547154,431128,42086,63869,176657,673658,545659,348660,142660,990661,804662,642663,507664,320665,191427,905428,22817,13917,25417,370005918,18618,652
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11,629
22,893
37,139
19,466
24,032
16,293
568,848
16,252
20,913
7,881
37,366
14,564
31,738
21,865
22,232
18,556
18,475
19,092
17,687
15,548
15,54817,68719,09218,47518,55622,23221,86531,73814,56437,3667,88120,91316,252568,84816,29324,03219,46637,13922,89311,62900000000000000000000000
> Total Liabilities 
57,705
102,885
103,404
0
79,844
101,336
89,962
95,719
403,296
460,118
793,785
750,960
713,997
746,855
716,614
678,568
612,086
619,706
886,145
836,018
883,294
938,605
956,394
1,174,880
1,135,075
1,204,370
1,103,771
1,140,427
1,085,006
1,066,714
1,175,684
899,509
883,805
871,087
804,506
697,724
1,008,745
1,057,152
1,142,465
989,722
752,184
736,971
501,955
501,955736,971752,184989,7221,142,4651,057,1521,008,745697,724804,506871,087883,805899,5091,175,6841,066,7141,085,0061,140,4271,103,7711,204,3701,135,0751,174,880956,394938,605883,294836,018886,145619,706612,086678,568716,614746,855713,997750,960793,785460,118403,29695,71989,962101,33679,8440103,404102,88557,705
   > Total Current Liabilities 
57,705
96,705
96,507
0
72,948
94,439
82,719
88,476
386,640
443,574
592,142
549,921
513,454
546,603
517,223
479,446
426,217
433,582
430,216
374,508
433,519
503,817
535,083
750,535
740,656
822,362
773,125
854,334
795,822
774,357
878,215
598,550
577,754
548,928
496,342
381,243
686,892
732,869
1,109,246
957,191
716,417
702,006
465,765
465,765702,006716,417957,1911,109,246732,869686,892381,243496,342548,928577,754598,550878,215774,357795,822854,334773,125822,362740,656750,535535,083503,817433,519374,508430,216433,582426,217479,446517,223546,603513,454549,921592,142443,574386,64088,47682,71994,43972,948096,50796,70557,705
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,760
624,061
637,591
711,541
642,181
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000642,181711,541637,591624,0615,7600000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,760
624,061
637,591
711,541
642,181
765,360
705,680
705,620
770,120
491,000
491,000
461,000
377,000
299,000
588,000
634,880
633,680
573,880
369,880
370,000
306,000
306,000370,000369,880573,880633,680634,880588,000299,000377,000461,000491,000491,000770,120705,620705,680765,360642,181711,541637,591624,0615,7600000000000000000000000
       Accounts payable 
50,857
93,467
88,233
0
0
82,643
72,221
75,810
126,951
122,998
121,253
90,804
94,763
80,259
104,280
113,650
82,715
72,453
66,190
67,342
98,308
80,199
55,908
80,958
58,406
67,026
59,673
59,736
67,984
33,576
57,238
58,976
55,371
51,892
52,346
41,663
52,861
52,178
76,292
88,305
84,257
66,365
83,003
83,00366,36584,25788,30576,29252,17852,86141,66352,34651,89255,37158,97657,23833,57667,98459,73659,67367,02658,40680,95855,90880,19998,30867,34266,19072,45382,715113,650104,28080,25994,76390,804121,253122,998126,95175,81072,22182,6430088,23393,46750,857
       Other Current Liabilities 
6,848
3,238
8,274
0
72,948
11,797
10,498
12,666
182,058
189,245
285,271
255,140
196,086
193,191
187,750
171,066
131,989
116,539
114,662
41,011
29,874
74,515
53,545
5,760
24,853
35,472
21,427
22,929
12,173
27,140
36,507
41,033
18,832
27,441
46,908
34,829
26,302
36,363
17,072
4,439
38,075
1,961
3,149
3,1491,96138,0754,43917,07236,36326,30234,82946,90827,44118,83241,03336,50727,14012,17322,92921,42735,47224,8535,76053,54574,51529,87441,011114,662116,539131,989171,066187,750193,191196,086255,140285,271189,245182,05812,66610,49811,79772,94808,2743,2386,848
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
424,345
394,419
382,008
330,646
286,093
289,184
292,357
297,469
300,959
306,051
322,159
308,164
316,481
321,853
324,283
33,219
32,531
35,767
34,965
36,189
36,18934,96535,76732,53133,219324,283321,853316,481308,164322,159306,051300,959297,469292,357289,184286,093330,646382,008394,419424,34500000000000000000000000
       Other Liabilities 
0
6,180
6,897
0
6,897
6,897
7,244
7,244
12,671
12,671
11,346
11,341
11,336
11,299
13,553
13,444
12,835
13,227
12,285
14,509
32,560
31,668
27,776
26,742
25,701
24,657
26,414
24,678
24,271
23,837
25,345
25,399
24,405
23,437
22,986
27,929
29,725
28,469
0
0
35,767
0
0
0035,7670028,46929,72527,92922,98623,43724,40525,39925,34523,83724,27124,67826,41424,65725,70126,74227,77631,66832,56014,50912,28513,22712,83513,44413,55311,29911,33611,34111,34612,67112,6717,2447,2446,8976,89706,8976,1800
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
29
7
6,673
16,591
23,232
32,632
37,390
37,731
38,244
38,226
34,728
35,394
29,056
29,127
15,596
16,244
10,854
10,936
0
0
14,426
0
0
0014,4260010,93610,85416,24415,59629,12729,05635,39434,72838,22638,24437,73137,39032,63223,23216,5916,67372900000000000000000000
> Total Stockholder Equity
225,507
285,335
350,140
350,140
380,942
719,806
735,640
756,271
776,382
782,979
804,299
824,378
835,396
858,210
886,574
905,404
926,169
953,393
1,042,840
1,067,862
1,019,021
1,064,774
1,111,204
1,021,016
1,072,412
1,115,436
1,153,038
1,211,904
1,063,838
1,065,310
1,080,432
1,122,181
1,024,570
1,052,204
1,261,690
1,307,590
1,179,475
1,215,891
1,403,139
1,509,260
1,407,860
1,713,700
2,010,682
2,010,6821,713,7001,407,8601,509,2601,403,1391,215,8911,179,4751,307,5901,261,6901,052,2041,024,5701,122,1811,080,4321,065,3101,063,8381,211,9041,153,0381,115,4361,072,4121,021,0161,111,2041,064,7741,019,0211,067,8621,042,840953,393926,169905,404886,574858,210835,396824,378804,299782,979776,382756,271735,640719,806380,942350,140350,140285,335225,507
   Common Stock
75,000
75,000
75,000
0
380,942
100,000
100,000
100,000
100,000
200,000
200,000
200,000
200,000
200,000
200,000
200,000
200,000
200,000
200,000
200,000
200,001
200,001
200,901
200,903
200,904
200,904
200,908
203,516
203,517
203,518
203,518
203,518
203,587
203,590
221,644
221,654
221,655
221,656
0
0
320,993
0
0
00320,99300221,656221,655221,654221,644203,590203,587203,518203,518203,518203,517203,516200,908200,904200,904200,903200,901200,001200,001200,000200,000200,000200,000200,000200,000200,000200,000200,000200,000200,000100,000100,000100,000100,000380,942075,00075,00075,000
   Retained Earnings 
95,914
147,884
204,633
0
0
281,880
297,714
318,345
338,456
345,053
363,819
383,770
394,569
417,296
445,596
464,310
484,849
511,980
536,939
561,734
512,696
558,338
592,486
424,365
475,550
518,465
633,609
656,532
508,361
509,742
524,788
566,457
467,781
495,335
519,384
565,051
436,772
473,075
438,925
544,396
556,627
478,396
517,500
517,500478,396556,627544,396438,925473,075436,772565,051519,384495,335467,781566,457524,788509,742508,361656,532633,609518,465475,550424,365592,486558,338512,696561,734536,939511,980484,849464,310445,596417,296394,569383,770363,819345,053338,456318,345297,714281,88000204,633147,88495,914
   Capital Surplus 0000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
68,385
68,489
65,953
66,185
66,383
66,491
66,548
59,381
59,467
59,554
59,625
59,705
59,628
59,661
59,749
59,829
59,965
60,064
0
0
44,606
0
0
0044,6060060,06459,96559,82959,74959,66159,62859,70559,62559,55459,46759,38166,54866,49166,38366,18565,95368,48968,38500000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue1,067,212
Cost of Revenue-467,988
Gross Profit599,224599,224
 
Operating Income (+$)
Gross Profit599,224
Operating Expense-756,401
Operating Income310,811-157,177
 
Operating Expense (+$)
Research Development43,064
Selling General Administrative187,668
Selling And Marketing Expenses0
Operating Expense756,401230,732
 
Net Interest Income (+$)
Interest Income11,982
Interest Expense-16,365
Other Finance Cost-442
Net Interest Income-4,825
 
Pretax Income (+$)
Operating Income310,811
Net Interest Income-4,825
Other Non-Operating Income Expenses0
Income Before Tax (EBT)292,994310,811
EBIT - interestExpense = -16,365
253,176
269,540
Interest Expense16,365
Earnings Before Interest and Taxes (EBIT)0309,359
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax292,994
Tax Provision-39,818
Net Income From Continuing Ops253,176253,176
Net Income253,176
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net04,825
 

Technical Analysis of Teyi Pharmaceutical Group Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Teyi Pharmaceutical Group Co Ltd. The general trend of Teyi Pharmaceutical Group Co Ltd is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Teyi Pharmaceutical Group Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Teyi Pharmaceutical Group Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 11.55 < 14.47 < 16.28.

The bearish price targets are: 9.0835026033691 > 8.814667953392 > 8.0428298393914.

Tweet this
Teyi Pharmaceutical Group Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Teyi Pharmaceutical Group Co Ltd. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Teyi Pharmaceutical Group Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Teyi Pharmaceutical Group Co Ltd. The current macd is -0.62948335.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Teyi Pharmaceutical Group Co Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Teyi Pharmaceutical Group Co Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Teyi Pharmaceutical Group Co Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Teyi Pharmaceutical Group Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartTeyi Pharmaceutical Group Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Teyi Pharmaceutical Group Co Ltd. The current adx is 20.99.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Teyi Pharmaceutical Group Co Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Teyi Pharmaceutical Group Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Teyi Pharmaceutical Group Co Ltd. The current sar is 16.15.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Teyi Pharmaceutical Group Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Teyi Pharmaceutical Group Co Ltd. The current rsi is 21.13. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
  • Trending down: The RSI is trending down. -1
Teyi Pharmaceutical Group Co Ltd Daily Relative Strength Index (RSI) ChartTeyi Pharmaceutical Group Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Teyi Pharmaceutical Group Co Ltd. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Teyi Pharmaceutical Group Co Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Teyi Pharmaceutical Group Co Ltd Daily Stochastic Oscillator ChartTeyi Pharmaceutical Group Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Teyi Pharmaceutical Group Co Ltd. The current cci is -448.07607784.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Teyi Pharmaceutical Group Co Ltd Daily Commodity Channel Index (CCI) ChartTeyi Pharmaceutical Group Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Teyi Pharmaceutical Group Co Ltd. The current cmo is -69.11942477.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Teyi Pharmaceutical Group Co Ltd Daily Chande Momentum Oscillator (CMO) ChartTeyi Pharmaceutical Group Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Teyi Pharmaceutical Group Co Ltd. The current willr is -98.98255814.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Teyi Pharmaceutical Group Co Ltd Daily Williams %R ChartTeyi Pharmaceutical Group Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Teyi Pharmaceutical Group Co Ltd.

Teyi Pharmaceutical Group Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Teyi Pharmaceutical Group Co Ltd. The current atr is 0.98547994.

Teyi Pharmaceutical Group Co Ltd Daily Average True Range (ATR) ChartTeyi Pharmaceutical Group Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Teyi Pharmaceutical Group Co Ltd. The current obv is 1,340,786,458.

Teyi Pharmaceutical Group Co Ltd Daily On-Balance Volume (OBV) ChartTeyi Pharmaceutical Group Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Teyi Pharmaceutical Group Co Ltd. The current mfi is 36.32.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Teyi Pharmaceutical Group Co Ltd Daily Money Flow Index (MFI) ChartTeyi Pharmaceutical Group Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Teyi Pharmaceutical Group Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-27ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-28STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-11-29RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-01STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-06RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-25STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-18CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-30BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-31ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-02-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-22CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-04CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-17WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-19WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-24BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

Teyi Pharmaceutical Group Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Teyi Pharmaceutical Group Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5021.127
Ma 20Greater thanMa 5015.159
Ma 50Greater thanMa 10015.140
Ma 100Greater thanMa 20016.684
OpenGreater thanClose9.720
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Teyi Pharmaceutical Group Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Teyi Pharmaceutical Group Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Teyi Pharmaceutical Group Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Teyi Pharmaceutical Group Co Ltd

I send you an email if I find something interesting about Teyi Pharmaceutical Group Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Teyi Pharmaceutical Group Co Ltd.

Receive notifications about Teyi Pharmaceutical Group Co Ltd in your mailbox!